News | September 21, 2008

Gene Expression May Predict Future Response for Cervical Cancer Patients

September 22, 2008 - Changes in gene expression during chemoradiation can predict the likelihood of response to therapy for women with locally advanced cervical cancer according to new research from the Radiation Therapy Oncology Group (RTOG) presented at ASTRO 2008.

RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

RTOG investigators examined tissue samples from 22 patients, including 13-paired samples, obtained prior to treatment and midway through treatment. The investigators found that changes in the gene signature pattern of seven genes predicted whether the woman’s cervical cancer would respond to treatment with a COX-2 inhibitor combined with chemoradiotherapy. Investigators did not find a pre-treatment or mid-treatment marker that predicted local control on its own, but rather it was the changes in gene expression from pre- to mid-treatment that predicted future response in 100 percent of the samples. The results were validated by leave one out and two-fold cross validation.

According to Joanne Weidhaas, M.D., Ph.D., lead author of the research from the Yale University Cancer Center, “This is an important first step towards tailoring therapy to individual patients. If we can predict midway through treatment how well a patient will respond to their therapy we can make treatment alterations earlier with a greater probability of improving outcome.”

The tissue samples were from patients entered on RTOG 0128, a phase I/II study of chemoradiation given with a COX-2 inhibitor for women with locally advanced cervical cancer. The women enrolled on this study received a five-week course of external radiation together with chemotherapy followed by brachytherapy that involved the insertion of two to five radioactive implants into the tumor site. Biopsies were done prior to the start of treatment and again at the time of the first brachytherapy application.

For more information: www.rtog.org, www.acr.org

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init